171 related articles for article (PubMed ID: 23042324)
1. Patent ductus arteriosus associated with pulmonary hypertension and desaturation.
Khositseth A; Wanitkun S
Cardiol J; 2012; 19(5):543-6. PubMed ID: 23042324
[TBL] [Abstract][Full Text] [Related]
2. Closure of large patent ductus arteriosus using the Amplatzer Septal Occluder.
García-Montes JA; Camacho-Castro A; Sandoval-Jones JP; Buendía-Hernández A; Calderón-Colmenero J; Patiño-Bahena E; Zabal C
Cardiol Young; 2015 Mar; 25(3):491-5. PubMed ID: 24555910
[TBL] [Abstract][Full Text] [Related]
3. The pulmonary vascular bed in children with Down syndrome.
Chi TPL?Krovetz J
J Pediatr; 1975 Apr; 86(4):533-8. PubMed ID: 123955
[TBL] [Abstract][Full Text] [Related]
4. Effect of patent ductus arteriosus on pulmonary vascular disease.
Philip R; Nathaniel Johnson J; Naik R; Kimura D; Boston U; Chilakala S; Hendrickson B; Rush Waller B; Sathanandam S
Congenit Heart Dis; 2019 Jan; 14(1):37-41. PubMed ID: 30811787
[TBL] [Abstract][Full Text] [Related]
5. Frequency of pulmonary hypertension in patients of differing ages with atrial or ventricular septal defects and patent ductus arteriosus.
Leachman RD; De Franceschi A; Runge TM; Cokkinos DV
Acta Cardiol; 1971; 26(5):480-90. PubMed ID: 5316234
[No Abstract] [Full Text] [Related]
6. Intermediate- and long-term follow-up of device closure of patent arterial duct with severe pulmonary hypertension: factors predicting outcome.
Sadiq M; Rehman AU; Hyder N; Qureshi AU; Kazmi T; Qureshi SA
Cardiol Young; 2017 Jan; 27(1):26-36. PubMed ID: 27133447
[TBL] [Abstract][Full Text] [Related]
7. Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech
Lehner A; Ulrich S; Happel CM; Fischer M; Kantzis M; Schulze-Neick I; Haas NA
Catheter Cardiovasc Interv; 2017 Mar; 89(4):718-725. PubMed ID: 27860161
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of transcatheter closure of large patent ductus arteriosus in adults with a self-expandable occluder.
Yu ML; Huang XM; Wang JF; Qin YW; Zhao XX; Zheng X
Heart Vessels; 2009 Nov; 24(6):440-5. PubMed ID: 20108077
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults.
Yan C; Zhao S; Jiang S; Xu Z; Huang L; Zheng H; Ling J; Wang C; Wu W; Hu H; Zhang G; Ye Z; Wang H
Heart; 2007 Apr; 93(4):514-8. PubMed ID: 16954130
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous closure of multiple atrial septal defects and patent ductus arteriosus during the same session.
Odemiş E; Ozyılmaz I; Güzeltaş A
Turk Kardiyol Dern Ars; 2012 Dec; 40(8):726-8. PubMed ID: 23518889
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous closure of a gigantic patent ductus arteriosus (PDA) with pulmonary hypertension with an atrial septal defect occluder in a 35-year-old woman.
Froehle M; Haas NA; Sandica E; Happel C; Laser KT
Clin Res Cardiol; 2014 Apr; 103(4):319-23. PubMed ID: 24356938
[No Abstract] [Full Text] [Related]
12. Percutaneous device closure of patent ductus arteriosus with pulmonary artery hypertension: long-term results.
Vijayalakshmi IB; Setty N; Narasimhan C; Singla V; Manjunath CN
J Interv Cardiol; 2014 Dec; 27(6):563-9. PubMed ID: 25490863
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: relationship between PDA type and risk of device protrusion into the descending aorta.
Masri S; El Rassi I; Arabi M; Tabbakh A; Bitar F
Catheter Cardiovasc Interv; 2015 Aug; 86(2):E66-72. PubMed ID: 26032159
[TBL] [Abstract][Full Text] [Related]
14. Trial occlusion to assess the risk of persistent pulmonary arterial hypertension after closure of a large patent ductus arteriosus in adolescents and adults with elevated pulmonary artery pressure.
Zhang DZ; Zhu XY; Lv B; Cui CS; Han XM; Sheng XT; Wang QG; Zhang P
Circ Cardiovasc Interv; 2014 Aug; 7(4):473-81. PubMed ID: 25097200
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.
Zeng WJ; Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Gu Q; Zhao ZH; Li JJ; He JG;
Clin Cardiol; 2011 Aug; 34(8):513-8. PubMed ID: 21678455
[TBL] [Abstract][Full Text] [Related]
16. Simple cardiac shunts in adults: atrial septal defects, ventricular septal defects, patent ductus arteriosus.
Tobler D; Greutmann M
Heart; 2020 Feb; 106(4):307-314. PubMed ID: 31911502
[No Abstract] [Full Text] [Related]
17. Safety and Outcomes of Transcatheter Closure of Patent Ductus Arteriosus in Children With Pulmonary Artery Hypertension.
Salavitabar A; Krishnan US; Turner ME; Vincent JA; Torres AJ; Crystal MA
Tex Heart Inst J; 2020 Aug; 47(4):250-257. PubMed ID: 33472220
[TBL] [Abstract][Full Text] [Related]
18. Contemporary outcomes of percutaneous closure of patent ductus arteriosus in adolescents and adults.
P S; Jose J; George OK
Indian Heart J; 2018; 70(2):308-315. PubMed ID: 29716712
[TBL] [Abstract][Full Text] [Related]
19. Eisenmenger syndrome in an adult patient with a large patent ductus arteriosus.
Dimopoulos K
Eur Respir Rev; 2013 Dec; 22(130):558-64. PubMed ID: 24293472
[TBL] [Abstract][Full Text] [Related]
20. [Successful closure of a large PDA with an Amplazter septal occluder in a child with heart failure and pulmonary hypertension--a case report].
Moszura T; Niwald M; Dryzek P; Moll J; Sysa A
Kardiol Pol; 2006 Nov; 64(11):1284-6. PubMed ID: 17165165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
